PMID- 23568326 OWN - NLM STAT- MEDLINE DCOM- 20140324 LR - 20211021 IS - 1740-634X (Electronic) IS - 0893-133X (Print) IS - 0893-133X (Linking) VI - 38 IP - 10 DP - 2013 Sep TI - Social play behavior in adolescent rats is mediated by functional activity in medial prefrontal cortex and striatum. PG - 1899-909 LID - 10.1038/npp.2013.83 [doi] AB - Social play behavior is a characteristic, vigorous form of social interaction in young mammals. It is highly rewarding and thought to be of major importance for social and cognitive development. The neural substrates of social play are incompletely understood, but there is evidence to support a role for the prefrontal cortex (PFC) and striatum in this behavior. Using pharmacological inactivation methods, ie, infusions of GABA receptor agonists (baclofen and muscimol; B&M) or the AMPA/kainate receptor antagonist 6,7-dinitroquinoxaline-2,3(1H,4H)-dione (DNQX), we investigated the involvement of several subregions of the medial PFC and striatum in social play. Inactivation of the prelimbic cortex, infralimbic cortex, and medial/ventral orbitofrontal cortex using B&M markedly reduced frequency and duration of social play behavior. Local administration of DNQX into the dorsomedial striatum increased the frequency and duration of social play, whereas infusion of B&M tended to have the same effect. Inactivation of the nucleus accumbens (NAcc) core using B&M increased duration but not frequency of social play, whereas B&M infusion into the NAcc shell did not influence social play behavior. Thus, functional integrity of the medial PFC is important for the expression of social play behavior. Glutamatergic inputs into the dorsomedial striatum exert an inhibitory influence on social play, and functional activity in the NAcc core acts to limit the length of playful interactions. These results highlight the importance of prefrontal and striatal circuits implicated in cognitive control, decision making, behavioral inhibition, and reward-associated processes in social play behavior. FAU - van Kerkhof, Linda W M AU - van Kerkhof LW AD - Rudolf Magnus Institute of Neuroscience, Department of Neuroscience and Pharmacology, University Medical Centre Utrecht, Utrecht, The Netherlands. FAU - Damsteegt, Ruth AU - Damsteegt R FAU - Trezza, Viviana AU - Trezza V FAU - Voorn, Pieter AU - Voorn P FAU - Vanderschuren, Louk J M J AU - Vanderschuren LJ LA - eng GR - R01 DA022628/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130408 PL - England TA - Neuropsychopharmacology JT - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology JID - 8904907 RN - 0 (Excitatory Amino Acid Antagonists) RN - 0 (GABA-B Receptor Agonists) RN - 0 (Quinoxalines) RN - 2763-96-4 (Muscimol) RN - 62T278S1MX (FG 9041) RN - H789N3FKE8 (Baclofen) SB - IM MH - Animals MH - Baclofen/administration & dosage/pharmacology MH - Corpus Striatum/drug effects/*physiology MH - Excitatory Amino Acid Antagonists/administration & dosage/pharmacology MH - GABA-B Receptor Agonists/administration & dosage/pharmacology MH - Male MH - Microinjections MH - Muscimol/administration & dosage/pharmacology MH - Nucleus Accumbens/drug effects/physiology MH - Prefrontal Cortex/drug effects/*physiology MH - Quinoxalines/administration & dosage/pharmacology MH - Rats MH - *Social Behavior PMC - PMC3746695 EDAT- 2013/04/10 06:00 MHDA- 2014/03/25 06:00 PMCR- 2014/09/01 CRDT- 2013/04/10 06:00 PHST- 2012/12/07 00:00 [received] PHST- 2013/03/29 00:00 [revised] PHST- 2013/04/03 00:00 [accepted] PHST- 2013/04/10 06:00 [entrez] PHST- 2013/04/10 06:00 [pubmed] PHST- 2014/03/25 06:00 [medline] PHST- 2014/09/01 00:00 [pmc-release] AID - npp201383 [pii] AID - 10.1038/npp.2013.83 [doi] PST - ppublish SO - Neuropsychopharmacology. 2013 Sep;38(10):1899-909. doi: 10.1038/npp.2013.83. Epub 2013 Apr 8.